193 related articles for article (PubMed ID: 27368132)
1. Knockdown delta-5-desaturase promotes the formation of a novel free radical byproduct from COX-catalyzed ω-6 peroxidation to induce apoptosis and sensitize pancreatic cancer cells to chemotherapy drugs.
Yang X; Xu Y; Brooks A; Guo B; Miskimins KW; Qian SY
Free Radic Biol Med; 2016 Aug; 97():342-350. PubMed ID: 27368132
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of delta-5-desaturase promotes the anti-cancer activity of dihomo-γ-linolenic acid and enhances the efficacy of chemotherapy in colon cancer cells expressing COX-2.
Xu Y; Yang X; Zhao P; Yang Z; Yan C; Guo B; Qian SY
Free Radic Biol Med; 2016 Jul; 96():67-77. PubMed ID: 27101738
[TBL] [Abstract][Full Text] [Related]
3. Dihomo-γ-linolenic acid inhibits growth of xenograft tumors in mice bearing human pancreatic cancer cells (BxPC-3) transfected with delta-5-desaturase shRNA.
Yang X; Xu Y; Gao D; Yang L; Qian SY
Redox Biol; 2019 Jan; 20():236-246. PubMed ID: 30384258
[TBL] [Abstract][Full Text] [Related]
4. Knockdown delta-5-desaturase in breast cancer cells that overexpress COX-2 results in inhibition of growth, migration and invasion via a dihomo-γ-linolenic acid peroxidation dependent mechanism.
Xu Y; Yang X; Wang T; Yang L; He YY; Miskimins K; Qian SY
BMC Cancer; 2018 Mar; 18(1):330. PubMed ID: 29587668
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of cancer migration and invasion by knocking down delta-5-desaturase in COX-2 overexpressed cancer cells.
Yang X; Xu Y; Wang T; Shu D; Guo P; Miskimins K; Qian SY
Redox Biol; 2017 Apr; 11():653-662. PubMed ID: 28157665
[TBL] [Abstract][Full Text] [Related]
6. Free radical derivatives formed from cyclooxygenase-catalyzed dihomo-γ-linolenic acid peroxidation can attenuate colon cancer cell growth and enhance 5-fluorouracil's cytotoxicity.
Xu Y; Qi J; Yang X; Wu E; Qian SY
Redox Biol; 2014; 2():610-8. PubMed ID: 25114837
[TBL] [Abstract][Full Text] [Related]
7. Dihomo-γ-linolenic acid inhibits xenograft tumor growth in mice bearing shRNA-transfected HCA-7 cells targeting delta-5-desaturase.
Xu Y; Yang X; Gao D; Yang L; Miskimins K; Qian SY
BMC Cancer; 2018 Dec; 18(1):1268. PubMed ID: 30567534
[TBL] [Abstract][Full Text] [Related]
8. Iminodibenzyl redirected cyclooxygenase-2 catalyzed dihomo-γ-linolenic acid peroxidation pattern in lung cancer.
Pang L; Shah H; Qian S; Sathish V
Free Radic Biol Med; 2021 Aug; 172():167-180. PubMed ID: 34102280
[TBL] [Abstract][Full Text] [Related]
9. Specific delivery of delta-5-desaturase siRNA via RNA nanoparticles supplemented with dihomo-γ-linolenic acid for colon cancer suppression.
Xu Y; Pang L; Wang H; Xu C; Shah H; Guo P; Shu D; Qian SY
Redox Biol; 2019 Feb; 21():101085. PubMed ID: 30584980
[TBL] [Abstract][Full Text] [Related]
10. Growth inhibitory and anti-metastatic activity of epithelial cell adhesion molecule targeted three-way junctional delta-5-desaturase siRNA nanoparticle for breast cancer therapy.
Shah H; Pang L; Wang H; Shu D; Qian SY; Sathish V
Nanomedicine; 2020 Nov; 30():102298. PubMed ID: 32931930
[TBL] [Abstract][Full Text] [Related]
11. EpCAM-Targeted 3WJ RNA Nanoparticle Harboring Delta-5-Desaturase siRNA Inhibited Lung Tumor Formation via DGLA Peroxidation.
Pang L; Shah H; Wang H; Shu D; Qian SY; Sathish V
Mol Ther Nucleic Acids; 2020 Dec; 22():222-235. PubMed ID: 33230429
[TBL] [Abstract][Full Text] [Related]
12. Delta-5-desaturase: A novel therapeutic target for cancer management.
Pang L; Shah H; Xu Y; Qian S
Transl Oncol; 2021 Nov; 14(11):101207. PubMed ID: 34438249
[TBL] [Abstract][Full Text] [Related]
13. The first characterization of free radicals formed from cellular COX-catalyzed peroxidation.
Gu Y; Xu Y; Law B; Qian SY
Free Radic Biol Med; 2013 Apr; 57():49-60. PubMed ID: 23261941
[TBL] [Abstract][Full Text] [Related]
14. 2D Nanomaterial, Ti
Sadiq M; Pang L; Johnson M; Sathish V; Zhang Q; Wang D
Biosensors (Basel); 2021 Feb; 11(2):. PubMed ID: 33557033
[TBL] [Abstract][Full Text] [Related]
15. Characterization of free radicals formed from COX-catalyzed DGLA peroxidation.
Xiao Y; Gu Y; Purwaha P; Ni K; Law B; Mallik S; Qian SY
Free Radic Biol Med; 2011 May; 50(9):1163-70. PubMed ID: 21310230
[TBL] [Abstract][Full Text] [Related]
16. Anti-cancer activities of ω-6 polyunsaturated fatty acids.
Xu Y; Qian SY
Biomed J; 2014; 37(3):112-9. PubMed ID: 24923568
[TBL] [Abstract][Full Text] [Related]
17. Predictive value of serum dihomo-γ-linolenic acid level and estimated Δ-5 desaturase activity in patients with hepatic steatosis.
Matsuda M; Kawamoto T; Tamura R
Obes Res Clin Pract; 2017; 11(1):34-43. PubMed ID: 26964726
[TBL] [Abstract][Full Text] [Related]
18. {Gamma}-tocotrienol inhibits pancreatic tumors and sensitizes them to gemcitabine treatment by modulating the inflammatory microenvironment.
Kunnumakkara AB; Sung B; Ravindran J; Diagaradjane P; Deorukhkar A; Dey S; Koca C; Yadav VR; Tong Z; Gelovani JG; Guha S; Krishnan S; Aggarwal BB
Cancer Res; 2010 Nov; 70(21):8695-705. PubMed ID: 20864511
[TBL] [Abstract][Full Text] [Related]
19. Concurrent inhibition of NF-kappaB, cyclooxygenase-2, and epidermal growth factor receptor leads to greater anti-tumor activity in pancreatic cancer.
Ali S; Banerjee S; Schaffert JM; El-Rayes BF; Philip PA; Sarkar FH
J Cell Biochem; 2010 May; 110(1):171-81. PubMed ID: 20213764
[TBL] [Abstract][Full Text] [Related]
20. Cyclooxygenase-2-dependent and -independent effects of celecoxib in pancreatic cancer cell lines.
El-Rayes BF; Ali S; Sarkar FH; Philip PA
Mol Cancer Ther; 2004 Nov; 3(11):1421-6. PubMed ID: 15542781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]